Skip to main content
Erschienen in: Medical Microbiology and Immunology 3/2005

01.05.2005 | Original Investigation

Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia

verfasst von: K. P. Ng, T. L. Saw, A. Baki, K. Rozainah, K. W. Pang, M. Ramanathan

Erschienen in: Medical Microbiology and Immunology | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

The implementation of the Expanded Program of Immunization (EPI) in 1989 has dramatic impact on hepatitis B virus (HBV) infection in school children in Malaysia. A cross-sectional seroprevalence study of HBV infection in 190,077 school children aged 7–12 years from 1997 to 2003 showed a steady decline of HBV surfacce antigen (HBsAg) prevalence rate from 2.5% for children born in 1985 to 0.4% among school children born in 1996. The overall prevalence of HBsAg was 0.6%, 0.7% in males and 0.6% in females. Over 92.7% of school children had been vaccinated with HBV vaccine, in which 93.7% were vaccinated under the EPI and 6.3% on voluntary basis. The school children vaccinated under EPI had a 0.4% HBsAg carrier rate, which was significantly lower than school children vaccinated on a voluntary basis (HBsAg carrier rate 1.3%) and non-vaccinated school children (HBsAg carrier rate 2.7%), suggesting that HBV vaccination of infants was the most effective measure in preventing vertical transmission of HBV in the hyperendemic region.
Literatur
1.
Zurück zum Zitat Gust ID (1996) Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38 (Suppl 2):S18–S23PubMed Gust ID (1996) Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut 38 (Suppl 2):S18–S23PubMed
2.
Zurück zum Zitat Campbell DH, Plant AJ, Sargent JW, Mock PA, et al (1991) Hepatitis B infection of children in a mixed-race community in western New South Wales. Med J Aust 154:253–256PubMed Campbell DH, Plant AJ, Sargent JW, Mock PA, et al (1991) Hepatitis B infection of children in a mixed-race community in western New South Wales. Med J Aust 154:253–256PubMed
3.
Zurück zum Zitat Guan R (1996) Hepatitis B virus infection in Singapore. Gut 38 (Suppl 2):S13–S17PubMed Guan R (1996) Hepatitis B virus infection in Singapore. Gut 38 (Suppl 2):S13–S17PubMed
4.
Zurück zum Zitat Ton SH, Lopez CG, Cheong KS, Noriah R (1984) Infectiousness with respect to HBV of medical staff and patients in the General Hospital, Kuala Lumpur. Singapore Med J 25:244–246PubMed Ton SH, Lopez CG, Cheong KS, Noriah R (1984) Infectiousness with respect to HBV of medical staff and patients in the General Hospital, Kuala Lumpur. Singapore Med J 25:244–246PubMed
5.
Zurück zum Zitat Lopez CG (1985) Epidemiology of persistent hepatitis B virus infection. Malaysian J Pathol 7:7–10 Lopez CG (1985) Epidemiology of persistent hepatitis B virus infection. Malaysian J Pathol 7:7–10
6.
Zurück zum Zitat Beasley RP, Hwang LY (1983) Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 143:185–190 Beasley RP, Hwang LY (1983) Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 143:185–190
7.
Zurück zum Zitat Stevens CE, Neurath RA, Beasley RP, et al (1979) HBeAg and anti-HBs detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B in Taiwan. J Med Virol 3:237–241PubMed Stevens CE, Neurath RA, Beasley RP, et al (1979) HBeAg and anti-HBs detection by radioimmunoassay. Correlation with vertical transmission of hepatitis B in Taiwan. J Med Virol 3:237–241PubMed
8.
Zurück zum Zitat Margolis HS (1990) The road ahead—future policy for the elimination of hepatitis B transmission in the United States. Proceeding of the 24th National Immunization Conference. US Department of Health and Human Services, Washington D.C., pp 33–37 Margolis HS (1990) The road ahead—future policy for the elimination of hepatitis B transmission in the United States. Proceeding of the 24th National Immunization Conference. US Department of Health and Human Services, Washington D.C., pp 33–37
9.
Zurück zum Zitat Wong VCW, Ip HMH, Reesink HW, Lelie PN, Reerink-Brongers EE, et al (1984) Prevention of HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet I:921–926CrossRef Wong VCW, Ip HMH, Reesink HW, Lelie PN, Reerink-Brongers EE, et al (1984) Prevention of HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet I:921–926CrossRef
10.
Zurück zum Zitat Goh KT (1995) Acute hepatitis B survillance in Singapore. Epidemiol News Bull 21:33–34 Goh KT (1995) Acute hepatitis B survillance in Singapore. Epidemiol News Bull 21:33–34
11.
Zurück zum Zitat Tsen YJ, Chang MN, Hsu HY Y, et al (1991) Seroprevalence of hepatitis B infection in children in Taipei 1989: five years after a mass hepatitis B vaccination programme. J Med Virol 34:96–99PubMed Tsen YJ, Chang MN, Hsu HY Y, et al (1991) Seroprevalence of hepatitis B infection in children in Taipei 1989: five years after a mass hepatitis B vaccination programme. J Med Virol 34:96–99PubMed
12.
Zurück zum Zitat Chen DS, Sung JL, Lai MY (1978) A seroepidemiological study of hepatitis B infection in Taiwan. J Formosa Med Assoc 77:908–918 Chen DS, Sung JL, Lai MY (1978) A seroepidemiological study of hepatitis B infection in Taiwan. J Formosa Med Assoc 77:908–918
13.
Zurück zum Zitat Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, et al (1982) Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 146:198–204PubMed Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, et al (1982) Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 146:198–204PubMed
14.
Zurück zum Zitat Szmuness W, Harley EJ, Ikram H, Stevens CE (1978) Sociodemographic aspects of the epidemiology of hepatitis B. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis: a contemporary assessment of etiology, epidemiology, pathogenesis and prevention. Franklin Institute Press, Philadelphia, pp 297–320 Szmuness W, Harley EJ, Ikram H, Stevens CE (1978) Sociodemographic aspects of the epidemiology of hepatitis B. In: Vyas GN, Cohen SN, Schmid R (eds) Viral hepatitis: a contemporary assessment of etiology, epidemiology, pathogenesis and prevention. Franklin Institute Press, Philadelphia, pp 297–320
15.
Zurück zum Zitat Vann Mayans M, Hall AJ, Inskip HM, et al (1990) Risk factors for transmission of hepatitis B virus to Gambian children. Lancet 336:1107–1109CrossRefPubMed Vann Mayans M, Hall AJ, Inskip HM, et al (1990) Risk factors for transmission of hepatitis B virus to Gambian children. Lancet 336:1107–1109CrossRefPubMed
16.
Zurück zum Zitat Gust ID, Dimitrakakis M, Zimmet P (1978) Studies of hepatitis B surface antigen and antibody in Nauru. I. Distribution among Nauruans. Am J Trop Med Hyg 27:1030–1036 Gust ID, Dimitrakakis M, Zimmet P (1978) Studies of hepatitis B surface antigen and antibody in Nauru. I. Distribution among Nauruans. Am J Trop Med Hyg 27:1030–1036
17.
Zurück zum Zitat Milne A, Allwood GK, Moyes CD, et al (1989) Prevalence of hepatitis B infections in a multiracial New Zealand community. N Z Med J 98:529–532 Milne A, Allwood GK, Moyes CD, et al (1989) Prevalence of hepatitis B infections in a multiracial New Zealand community. N Z Med J 98:529–532
18.
Zurück zum Zitat CDC (1988) Recommendations of the Immunization Practices Advisory Committee. Prevention of perinatal trasnsmission of hepatitis B virus. Prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR 37:341–356 CDC (1988) Recommendations of the Immunization Practices Advisory Committee. Prevention of perinatal trasnsmission of hepatitis B virus. Prenatal screening of all pregnant women for hepatitis B surface antigen. MMWR 37:341–356
19.
Zurück zum Zitat Margolis HS, Coleman PJ, Brown RE, Mast EE, et al (1995) Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 274:1201–1208CrossRefPubMed Margolis HS, Coleman PJ, Brown RE, Mast EE, et al (1995) Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA 274:1201–1208CrossRefPubMed
Metadaten
Titel
Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia
verfasst von
K. P. Ng
T. L. Saw
A. Baki
K. Rozainah
K. W. Pang
M. Ramanathan
Publikationsdatum
01.05.2005
Verlag
Springer-Verlag
Erschienen in
Medical Microbiology and Immunology / Ausgabe 3/2005
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-004-0231-4

Weitere Artikel der Ausgabe 3/2005

Medical Microbiology and Immunology 3/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.